Kineta Inc. (NASDAQ: KA)
$0.73
-0.0020 ( -0.27% ) 87.3K
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
Market Data
Open
$0.73
Previous close
$0.73
Volume
87.3K
Market cap
$8.69M
Day range
$0.71 - $0.79
52 week range
$0.33 - $5.39
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Apr 16, 2024 |
| 4 | Insider transactions | 1 | Apr 16, 2024 |
| 4 | Insider transactions | 1 | Apr 16, 2024 |
| 4 | Insider transactions | 1 | Apr 16, 2024 |
| 8-k | 8K-related | 13 | Apr 08, 2024 |
| 8-k | 8K-related | 13 | Mar 21, 2024 |
| 10-k | Annual reports | 126 | Mar 21, 2024 |
| 8-k | 8K-related | 52 | Mar 12, 2024 |
| 8-k | 8K-related | 16 | Feb 29, 2024 |
| 8-k | 8K-related | 12 | Jan 17, 2024 |